Suppr超能文献

一氧化氮、环磷酸鸟苷(cGMP)和环磷酸腺苷(cAMP)调节妊娠期糖尿病患者人脐动脉平滑肌细胞中对硝基苄硫基肌苷敏感的腺苷转运。

Nitric oxide, cGMP and cAMP modulate nitrobenzylthioinosine-sensitive adenosine transport in human umbilical artery smooth muscle cells from subjects with gestational diabetes.

作者信息

Aguayo C, Sobrevia L

机构信息

Cellular and Molecular Physiology Laboratory (CMPL), Department of Physiology, Faculty of Biological Sciences, University of Concepcion, PO Box 160-C, Concepcion, Chile.

出版信息

Exp Physiol. 2000 Jul;85(4):399-409.

Abstract

Adenosine transport was characterized in human umbilical artery smooth muscle cells isolated from non-diabetic and diabetic pregnant subjects. Transport of adenosine was mediated by a Na+-independent transport system inhibited by nanomolar concentrations of nitrobenzylthioinosine (NBMPR) in both cell types. Diabetes increased adenosine transport, an effect that was associated with a higher maximal velocity (Vmax) for NBMPR-sensitive (es) saturable nucleoside transport (18 +/- 2 vs. 61 +/- 3 pmol (microgram protein)-1 min-1, P < 0.05) and the maximal number of binding sites (Bmax) for specific [3H]NBMPR binding (74 +/- 4 vs. 156 +/- 10 pmol (microgram protein)-1, P < 0.05), with no significant changes in the Michaelis-Menten (Km) and dissociation (Kd) constants, respectively. Adenosine transport was unaltered by inhibition of nitric oxide (NO) synthase (with 100 microM NG-nitro-L-arginine methyl ester, L-NAME) or protein synthesis (with 1 microM cycloheximide), but was increased by inhibition of adenylyl cyclase activity (with 100 microM, SQ-22536) in non-diabetic cells. Diabetes-induced adenosine transport was blocked by L-NAME and associated with an increase in L-[3H]citrulline formation from L-[3H]arginine and intracellular cGMP, but with a decrease in intracellular cAMP compared with non-diabetic cells. Expression of inducible NO synthase (iNOS) was unaltered by diabetes. Dibutyryl cGMP (dbcGMP) increased, but dibutyryl cAMP (dbcAMP) decreased, adenosine transport in non-diabetic cells. dbcGMP or the NO donor S-nitrosoacetylpenicillamine (SNAP, 100 microM) did not alter the diabetes-elevated adenosine transport. However, activation of adenylyl cyclase with forskolin (1 microM), directly or after incubation of cells with dbcAMP, inhibited adenosine transport in both cell types. Our findings provide the first evidence that adenosine transport in human umbilical artery smooth muscle cells is mediated by the NBMPR-sensitive transport system es, and that its activity is upregulated by gestational diabetes.

摘要

对从非糖尿病和糖尿病孕妇体内分离出的人脐动脉平滑肌细胞中的腺苷转运进行了特性研究。在这两种细胞类型中,腺苷的转运均由一种不依赖钠离子的转运系统介导,该系统可被纳摩尔浓度的硝基苄硫基肌苷(NBMPR)抑制。糖尿病会增加腺苷转运,这种效应与NBMPR敏感(es)的可饱和核苷转运的更高最大速度(Vmax)(18±2对61±3皮摩尔/(微克蛋白)-1分钟-1,P<0.05)以及特异性[3H]NBMPR结合的最大结合位点数(Bmax)(74±4对156±10皮摩尔/(微克蛋白)-1,P<0.05)相关,而米氏(Km)常数和解离(Kd)常数分别无显著变化。抑制一氧化氮(NO)合酶(用100微摩尔NG-硝基-L-精氨酸甲酯,L-NAME)或蛋白质合成(用1微摩尔环己酰亚胺)不会改变腺苷转运,但在非糖尿病细胞中,抑制腺苷酸环化酶活性(用100微摩尔,SQ-22536)会增加腺苷转运。糖尿病诱导的腺苷转运被L-NAME阻断,并与L-[3H]精氨酸生成L-[3H]瓜氨酸以及细胞内cGMP增加相关,但与非糖尿病细胞相比,细胞内cAMP减少。糖尿病不会改变诱导型NO合酶(iNOS)的表达。二丁酰cGMP(dbcGMP)会增加,但二丁酰cAMP(dbcAMP)会减少非糖尿病细胞中的腺苷转运。dbcGMP或NO供体S-亚硝基乙酰青霉胺(SNAP,100微摩尔)不会改变糖尿病升高的腺苷转运。然而,用福司可林(1微摩尔)直接激活腺苷酸环化酶或在细胞与dbcAMP孵育后激活,会抑制这两种细胞类型中的腺苷转运。我们的研究结果首次证明,人脐动脉平滑肌细胞中的腺苷转运由NBMPR敏感的转运系统es介导,并且其活性在妊娠期糖尿病中上调。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验